Connect with us

Business

Petrol, Diesel Fresh Prices Announced: Check Rates In Your City On October 7

Published

on

Petrol, Diesel Fresh Prices Announced: Check Rates In Your City On October 7


Last Updated:

Petrol, Diesel Price On October 7: Check City-Wise Rates Across India Including In Delhi, Mumbai and Chennai.

Petrol, Diesel Prices On October 7.

Petrol, Diesel Prices On October 7.

Petrol and Diesel Prices on October 7, 2025: OMCs update petrol and diesel prices daily at 6 AM, aligning them with fluctuations in global crude oil prices and currency exchange rates. This daily revision promotes transparency and ensures consumers have access to the most up-to-date and accurate fuel prices.

Petrol Diesel Price Today In India

Check city-wise petrol and diesel prices on October 7:

City Petrol (₹/L) Diesel (₹/L)
New Delhi 94.72 87.62
Mumbai 104.21 92.15
Kolkata 103.94 90.76
Chennai 100.75 92.34
Ahmedabad 94.49 90.17
Bengaluru 102.92 89.02
Hyderabad 107.46 95.70
Jaipur 104.72 90.21
Lucknow 94.69 87.80
Pune 104.04 90.57
Chandigarh 94.30 82.45
Indore 106.48 91.88
Patna 105.58 93.80
Surat 95.00 89.00
Nashik 95.50 89.50

Key Factors Behind Petrol and Diesel Rates

Petrol and diesel prices in India have remained unchanged since May 2022, following tax reductions by the central and several state governments.

Oil Marketing Companies (OMCs) update fuel prices daily at 6 am, adjusting for fluctuations in global crude oil markets. While these rates are technically market-linked, they are also influenced by regulatory measures such as excise duties, base pricing frameworks, and informal price caps.

Key Factors Influencing Fuel Prices in India

  • Crude Oil Prices: Global crude oil prices are a primary driver of fuel prices, as crude is the main input in petrol and diesel production.

  • Exchange Rate: Since India relies heavily on crude oil imports, the value of the Indian rupee against the US dollar significantly affects fuel costs. A weaker rupee typically translates to higher prices.

  • Taxes: Central and state-level taxes constitute a major portion of retail fuel prices. Tax rates vary across states, leading to regional price differences.

  • Refining Costs: The cost of processing crude oil into usable fuel impacts retail prices. These costs can fluctuate depending on crude quality and refinery efficiency.

  • Demand-Supply Dynamics: Market demand also influences fuel pricing. Higher demand can push prices up as supply adjusts to consumption trends.

How to Check Petrol and Diesel Prices via SMS

You can easily check the latest petrol and diesel prices in your city through SMS. For Indian Oil customers, text the city code followed by “RSP” to 9224992249. BPCL customers can send “RSP” to 9223112222, and HPCL customers can text “HP Price” to 9222201122 to receive the current fuel prices.

Aparna Deb

Aparna Deb

Aparna Deb is a Subeditor and writes for the business vertical of News18.com. She has a nose for news that matters. She is inquisitive and curious about things. Among other things, financial markets, economy, a…Read More

Aparna Deb is a Subeditor and writes for the business vertical of News18.com. She has a nose for news that matters. She is inquisitive and curious about things. Among other things, financial markets, economy, a… Read More

Click here to add News18 as your preferred news source on Google. Stay updated with all the latest business news, including market trendsstock updatestax, IPO, banking finance, real estate, savings and investments. To Get in-depth analysis, expert opinions, and real-time updates. Also Download the News18 App to stay updated.
News business Petrol, Diesel Fresh Prices Announced: Check Rates In Your City On October 7
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Business

Cambridge shelter resident says Budget must focus on housing

Published

on

Cambridge shelter resident says Budget must focus on housing


A man experiencing homelessness said he hoped the government would focus on increasing accessibility to housing in its upcoming Budget.

Josh, 26, who is currently a resident at the night shelter Jimmy’s in Cambridge, said the availability of council housing and “move-on housing” – shared accommodation where people can receive support – was important.

Chancellor Rachel Reeves will deliver Labour’s second budget on 26 November.

Cambridge City Council received 1,139 homelessness applications between April 2024 and March 2025, which was a 13% rise on the previous year.

Josh said his focus was to get back into work after he completed his electrician qualifications, which he said were “just as hard as a degree in my opinion”.

He would like to see the Budget include more opportunities for continuing apprenticeships and more financial support for necessities such as course books.

Josh said he recently received a government grant to pay for essential job hunting equipment, such as a mobile phone, boots and suitable clothing.

He added that he would support a rise in taxes if they were spent on investing in public services, “especially the train lines into London”.

Andrew works in the security sector and lives in Peterborough in a home owned by the charity Hope Into Action.

The charity, which was set up in the city 15 years ago, owns 130 houses across the UK.

Andrew has beea living in one of the charity’s properties for two years, after experiencing homelessness for about “three or four months”.

“The charity saved my life,” he said.

He said renting in the private sector “can be expensive” but that people themselves have “got to budget as much as possible”.

Applications for housing to Peterborough City Council are also rising.

In 2024, it was contacted by 3,654 households facing homelessness, which was an 11% jump on the previous year.

And since 7 April this year, there have already been 2,333 approaches – an average of 70 a week.

The authority received nearly £1m last month to help tackle rough sleeping in the city.

Andrew said he recognised that public services needed to be paid for and that if tax rises needed to happen to pay for them then “you’ve got to make good” yourself.

HM Treasury was contacted for comment.



Source link

Continue Reading

Business

Kotak Mahindra stock split: Bank announces 1:5 share split; aims to boost liquidity- what you need to know – The Times of India

Published

on

Kotak Mahindra stock split: Bank announces 1:5 share split; aims to boost liquidity- what you need to know – The Times of India


Kotak Mahindra Bank on Friday said its board has approved a sub-division of equity shares in a 1:5 ratio to make the stock more affordable and enhance market liquidity. The decision was taken on the lender’s 40th foundation day and is subject to statutory and regulatory approvals, the private sector bank said in a regulatory filing.Under the proposal, one existing equity share of face value Rs 5 will be split into five shares of face value Rs 1 each, fully paid-up. The lender last conducted a stock split in 2010, when it subdivided shares in a 1:2 ratio, PTI reported.Commenting on the decision, the bank’s part-time chairman CS Rajan said, “As we celebrate 40 years of our journey, we reaffirm our commitment to creating long-term value for our shareholders. This milestone is not just a reflection of our legacy, but a Kotak for the future.”He added that the move is intended to encourage broader investor participation by making equity shares “more affordable and liquid”.Managing Director and CEO Ashok Vaswani said, “Forty years ago, we began a journey rooted in trust and innovation. Today, as we celebrate this remarkable milestone, we also look ahead with a renewed ambition. The decision to implement a stock split echoes our commitment to inclusivity, so that more investors can join us in the Kotak growth story.”The board also approved amendments to the capital clause of the Memorandum of Association to reflect the revised share structure post-split. The change will take effect after necessary approvals from shareholders, the Reserve Bank of India, and other regulatory authorities.The process is expected to be completed within two months of receiving all clearances. Shares of Kotak Mahindra Bank closed 0.51% lower at Rs 2,086.50 apiece on the BSE on Friday.





Source link

Continue Reading

Business

Eli Lilly hits $1 trillion market value, a first for a health-care company

Published

on

Eli Lilly hits  trillion market value, a first for a health-care company


A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.

Scott Olson | Getty Images

Eli Lilly reached a $1 trillion market capitalization on Friday, the first health-care company in the world to join the exclusive club dominated by tech firms.

Eli Lilly briefly hit the $1 trillion mark in morning trading before retreating. It was last trading around $1,048 a share. Eli Lilly is the second nontechnology company to reach the coveted $1 trillion mark in the U.S. after Warren Buffett‘s Berkshire Hathaway.

The drugmaker’s stock has climbed more than 36% this year as investors applaud the gains it has made over chief rival Novo Nordisk in the GLP-1 drug space. The Indianapolis-based company’s stock has been riding the skyrocketing popularity of its weight loss injection Zepbound and diabetes treatment Mounjaro.

Stock Chart IconStock chart icon

Eli Lilly’s stock has soared on the back of the success of its drugs Mounjaro and Zepbound.Demand is only expected to grow as approvals for the treatments’ uses and insurance coverage expand.

The two drugs have driven eye-popping sales growth for Eli Lilly. Last month, the company said Mounjaro drew in $6.52 billion in revenue in the third quarter, a 109% increase from the previous year. Meanwhile, Zepbound posted $3.59 billion in sales during the period, a 184% spike from the prior-year period.

Demand for the treatments will only grow as approvals for their use and insurance coverage expand. In addition, Eli Lilly expects an oral version of its popular drugs to hit the market next year, which could give patients a more convenient option than a shot that is easier for the company to produce.

Eli Lilly will likely remain a dominant player in the weight loss drug market, which some analysts believe could be worth more than $150 billion by the early 2030s.

But despite its recent struggles and leadership shake-ups, Novo Nordisk remains a formidable rival for Eli Lilly in the space. Pfizer also made a push forward in the market, as well, when it won a $10 billion bidding war with Novo Nordisk for obesity drugmaker Metsera earlier this month.

The runaway success of Zepbound, Mounjaro

Eli Lilly, a pharmaceutical chemist and Union veteran of the U.S. Civil War, founded his namesake company in 1876. It has long been at the forefront of the diabetes treatment space, introducing the world’s first commercial insulin in 1923. 

Eli Lilly became a publicly traded company on the New York Stock Exchange by 1952, and for decades relied on a slate of widely successful products to drive much of its profits and revenue. That included insulins, the antidepressant pill Prozac and the earliest polio vaccine

An Eli Lilly & Co. Zepbound injection pen, March 28, 2024.

Bloomberg | Bloomberg | Getty Images

Eli Lilly hit the jackpot with the May 2022 approval of tirzepatide for diabetes, which is sold as Mounjaro. It started to compete with Novo Nordisk’s diabetes injection Ozempic, which had entered the market a few years earlier. 

But Eli Lilly brought a new way to treat diabetes and eventually, obesity. Tirzepatide works by imitating two hormones produced in the gut called GLP-1 and GIP. GLP-1 helps reduce food intake and appetite. GIP, which also suppresses appetite, may also improve how the body breaks down sugar and fat.

Meanwhile, Novo Nordisk’s semaglutide, the active ingredient in Ozempic and its weight loss drug Wegovy, only targets GLP-1. 

Mounjaro achieved “blockbuster” status — meaning it generated more than $1 billion in annual sales — during its first full year on the market. Eli Lilly then won approval in late 2023 for tirzepatide as a treatment for obesity, which is sold as Zepbound and now competes with Novo Nordisk’s Wegovy. 

By 2024, Mounjaro pulled in $11.54 billion in sales, while Zepbound posted $4.93 billion in revenue.

More CNBC health coverage



Source link

Continue Reading

Trending